You are using an outdated browser. Please upgrade your browser to improve your experience.

You are using an outdated browser.

To ensure optimal security, this website will soon be unavailable on this browser. Please upgrade your browser to allow continued use of ACP websites.

Controlling High Blood Pressure for People with Serious Mental Illness

The percentage of patients 18-85 years of age with serious mental illness who had a diagnosis of hypertension (HTN) and whose blood pressure (BP) was adequately controlled during the measurement year.
Note: This measure is adapted from an existing health plan measure used in a variety of reporting programs for the general population (NQF #0018: Controlling High Blood Pressure). It was originally endorsed in 2009 and is owned and stewarded by NCQA. The specifications for the existing measure (Controlling High Blood Pressure NQF #0018) have been updated based on 2013 JNC-8 guideline. NCQA will submit the revised specification for Controlling High Blood Pressure NQF #0018 in the 4th quarter 2014 during NQF’s scheduled measure update period. This measure uses the new specification to be consistent with the current guideline.

Date Reviewed: July 21, 2018

Measure Info

NQF 2602NQF Endorsed
Measure Type: 
Outcome
Measure Steward: 
National Committee for Quality Assurance
Clinical Topic Area: 
Hypertension

Care Setting: 
Outpatient
Data Source: 
Claims
Electronic Health Records
Paper Medical Records

ACP does not support NQF measure #2602: “Controlling High Blood Pressure for People with Serious Mental Illness” because the specifications are flawed and the measure is not based on the most current recommendations of the United States Preventive Services Task Force (USPSTF) and the American Heart Association (AHA) on blood pressure monitoring. Developers do not cite any information to validate the importance of implementing a “blood pressure control” measure to specifically target patients who are diagnosed with serious mental illness. Furthermore, the numerator specifies office screening as the preferred monitoring method, while the USPSTF recommends obtaining measurements outside of the clinical setting for diagnostic confirmation before starting treatment. Therefore, implementation could promote overuse of pharmacotherapy in patients whose blood pressure is adequately controlled in the ambulatory setting. We suggest developers update the numerator specifications to include an average of several measurements. Doing so will likely increase the accuracy of the measurement results and reduce the potential for overtreatment. Furthermore, this measure will not reward clinicians who help patients reduce blood pressure measurements outside of the parameters specified in the numerator. For example, clinicians who help patients reduce systolic blood pressure measurements from 180 mmHg to 145 mmHg will not receive credit for this measure. Also, the specifications should include some element of risk-adjustment. Treatment success will likely be confounded by the mental illness. This measure is specified to evaluate performance at the system-level of analysis and variations in assessment skills according to specialty and clinical expertise may produce unstable estimates. Finally, implementation at the individual clinical level of analysis poses significant provider burden because blood pressure data and mental health data may exist in separate medical records.

As part of an ongoing effort to improve user experience, we have made some updates to the Performance Measures section of ACP. Tell us what you think!